72 followers
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer. https://t.co/5aKLsArq37
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer. https://t.co/5aKLsArq37
New article: Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer. https://t.co/UryxoSmaB1 #uterinecancer #oncology https://t.co/hCnLXBAaSW
The cover for issue 29 of @Oncotarget features Figure 5, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model ," by Lara, et al. https://t.co/YW9kl3jO7w